Benitec Biopharma Announces Oversubscribed Private Placement Financing of $40.0 Million
GlobeNewswire
HAYWARD, Calif., April 18, 2024 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or the “Company”), a..
HAYWARD, Calif., April 18, 2024 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or the “Company”), a..
*First quarter** 2024 net income of **$26.1 million** and net income available to common **stockholders of **$21.8..
*Press Release*
*VRANKEN-POMMERY MONOPOLE*
*AVAILABILITY OF THE 2023 UNIVERSAL REGISTRATION..